We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Biology Lab Tools Speed Up Tumor Dissection

By LabMedica International staff writers
Posted on 12 Sep 2024
Print article
Image: Scanning microscopy images of the microDicer and microGrate (Photo courtesy of Seth Cordts and Saisneha Koppaka)
Image: Scanning microscopy images of the microDicer and microGrate (Photo courtesy of Seth Cordts and Saisneha Koppaka)

As intriguing as working in a modern biology lab can be, much of the time, it involves repetitive, detailed tasks that need to be completed before the actual research begins. For instance, cancer researchers today can test multiple cancer therapies, including immunotherapies, on hundreds or even thousands of small, lab-grown tumor samples called organoids. However, creating organoids often requires researchers to manually mince a fresh tumor into tiny pieces using scissors, cutting the specimen into submillimeter sizes. This tedious and time-consuming task is usually carried out by highly skilled – and often overqualified – graduate students or research scientists. Fortunately, those days may be coming to an end as researchers have developed two innovative tools to streamline the precision cutting of tumor samples into submillimeter-scale organoids.

Much like kitchen gadgets used to dice vegetables or grate cheese, the microDicer (µDicer) and microGrater (µGrater), developed by scientists at the Stanford School of Engineering (Stanford, CA, USA), promise to improve both the consistency and quality of samples. This is crucial, as it directly influences the accuracy of downstream experiments, such as drug response testing. In cancer immunotherapy research, preserving the spatial relationships between tumor cells and infiltrating immune cells is key to accurately testing therapies. These new tools allow researchers to more efficiently create organoids that retain these vital cellular relationships. As detailed in the journal Microsystems & Nanoengineering, which features the study on the microDicer and microGrater, the microDicer’s blades are made using micromachining techniques from the semiconductor industry. The silicon blades are etched into a reactive plasma, forming a honeycomb-like mesh with sharp edges. Researchers use the microDicer by shaving thin tissue layers and pressing them through this honeycomb mesh, creating precise, uniform tumor samples.

In contrast, the microGrater features an array of blades shaped like rounded rectangles, each slightly longer than half a millimeter. The beveled edges of these rectangles act as blades, shaving off precise organoids as the tissue is moved across the grater. The tumors being studied are grown in lab mice, serving as a reliable model for human tumors. Ultimately, the aim is to develop personalized cancer therapies by collecting samples from individual patients and testing which immunotherapies will be most effective for them. These new tools standardize the organoid preparation process in ways manual cutting cannot, potentially speeding up regulatory approvals, such as from the FDA, for broader clinical applications.

“These new tools will speed up the manual lab work, but their utility goes beyond that obvious advantage,” said Sindy Tang, an associate professor of mechanical engineering and senior author of the study. “These tools produce uniform-sized organoids and the blades can be varied to whatever size the researcher requires.”

Related Links:
Stanford University
Stanford Medicine

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TETANUS Test
TETANUS VIRCLIA IgG MONOTEST
New
Silver Member
ACTH Assay
ACTH ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.